Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Time is of the essence... Increased nasopharyngeal

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 153902
(Total Views: 637)
Posted On: 12/30/2020 12:06:46 AM
Avatar
Posted By: JLang
Re: invisioner #70178
Time is of the essence... Increased nasopharyngeal proliferation = increased viral load on transmission = likely worse disease progression / clinical outcomes.

The current vaccines will not roll out fast enough and wide enough to halt the pandemic; all they will do is select for a mutated virus that the vaccinated won't be protected against, which will become the dominant strain, and likely be able to infect those that have already been infected. At that point, hyperimmunity becomes a huge concern... will the second time around, with a similar but not quite the same strain, result in increased severity / death, like Dengue?

Quote:
SARS-CoV-2, the virus that causes COVID-19, mutates regularly and acquires about one new mutation in its genome every two weeks, according to the CDC. This particular variant, known as B117, has several mutations that affect the so-called "spiked protein" on the virus surface that attaches to human cells.

Researchers believe current COVID-19 vaccines will likely protect against the new variant, but data is needed. The virus would "likely need to accumulate multiple mutations in the spike protein to evade immunity induced by vaccines or by natural infection," according to the CDC.

Earlier this month, Vivek Murthy, President-elect Joe Biden’s nominee for surgeon general, urged Americans not to let concerns over the variant shake their faith in vaccination. "There’s no reason to believe that the vaccines that have been developed will not be effective against this virus as well," Murthy said on NBC’s "Meet the Press." {'No' reason? Try again, Vivek. That specific strain, perhaps, but that strain is set to increase spread and thus, mutation frequency... It's grandchildren will likely be the ones to overcome vaccination}

The emergence of a new variant of the SARS-CoV-2 virus isn’t surprising, said Dr. Monica Gandhi, a professor of infectious disease at the University of California, San Francisco. "A virus that can spread more readily from human to human has an evolutionary advantage," she said.

This mutation appears to produce a high viral load in the nose and the mouth, which are the main ways COVID-19 spreads. The more virus, the higher chance of infecting someone else.





(3)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us